CROMOPTIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cromoptic, and when can generic versions of Cromoptic launch?
Cromoptic is a drug marketed by King Pharms and is included in one NDA.
The generic ingredient in CROMOPTIC is cromolyn sodium. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cromoptic
A generic version of CROMOPTIC was approved as cromolyn sodium by SANDOZ on June 16th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CROMOPTIC?
- What are the global sales for CROMOPTIC?
- What is Average Wholesale Price for CROMOPTIC?
Summary for CROMOPTIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 98 |
| Patent Applications: | 4,783 |
| DailyMed Link: | CROMOPTIC at DailyMed |
US Patents and Regulatory Information for CROMOPTIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pharms | CROMOPTIC | cromolyn sodium | SOLUTION/DROPS;OPHTHALMIC | 075088-001 | Apr 27, 1999 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
